Prime Time for HLA Desensitization: Imlifidase in the Spotlight

Abstract

In this issue of Transplant International [7], a French expert transplant group endorsed by different French scientific societies (SFT, FNDT, SFHI), propose a set of clinical, immunological, and therapeutic recommendations on how to implement Imlifidase in clinical transplantation. The authors should be acknowledged for the thorough description of the different recommendations provided in this consensus report, especially considering the relatively low level of evidence currently available in this topic. Even though some recommendations are based on their national allocation policy, most of them may be perfectly generalized to any other transplant system worldwide.